The Effect of Melatonin on Increasing the Health Related Quality of Life in Non-Metastatic Breast Cancer Patients: Three-Year Follow up a Clinical Trial.
Zahra Keshtpour AmlashiFatemeh SheidaRobab AnbiaeeLeili TapakSeyed Rohallah HosseiniHossein MosaedianNastaran BaratiPublished in: Integrative cancer therapies (2024)
Long-term use of 18 mg of melatonin for 3 years in patients with non-metastatic breast cancer can lead to an increase in the patients' quality of life.